Research Paper Volume 15, Issue 21 pp 11918—11939
The development and experimental validation of hypoxia-related long noncoding RNAs prognostic signature in predicting prognosis and immunotherapy of cutaneous melanoma
Figure 8. Correlation analysis of risk score and drug sensitivity. IC 50 of (A) Paclitaxel, (B) Sorafenib, (C) AKT inhibitor VIII, (D) Rapamycin, (E) Pazopanib, (F) Lapatinib, (G) Crizotinib, and (H) Sunitinib. (I–P) Correlation analysis of risk score and frug sensitivity.